TITAN-HCC: Neoadjuvant and Adjuvant QL1706 With TACE in Resectable Hepatocellular Carcinoma Beyond Milan Criteria

Clinical trial NCT07268131 · RECRUITING

Trial details

NCT number: NCT07268131
Sponsor: Fudan University
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Hepatocellular Carcinoma (HCC)

Start date: 2025-12-09
Primary completion: 2026-10-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.